Biopharmaceutical industry and healthcare are being transformed by a variety of novel technolgies coming into research and business practises. From artificial intelligence and big data tools, to quantum computing, next generation proteomics, and virtual reality -- novel technologies are disrupting the traditional research and business models, and helping innovate at a greater scale, faster, and cheaper.
Fierce competition. Thin pipelines. Patent cliffs. The stakes are sky-high for pharmaceutical companies and investors alike. With biotech firms often …
In a collaborative effort between Brainomix, an AI-powered medical technology company, and AstraZeneca, a new study demonstrates significant advancements in …
A new five-year commercial agreement and go-to-market collaboration aims to merge 1910 Genetics' comprehensive computational and biological data with Microsoft’s HPC …
British Patient Capital has invested £10m in Southampton-based biotechnology firm Curve Therapeutics through its Future Fund: Breakthrough programme and co-investment …
(Updated: 24.02.2024) Molecular mechanics (MM) is a traditional computational approach when it comes to modeling in synthetic organic chemistry, medicinal …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.